COPYRIGHT,O
2020,DATE
BY,O
THE,O
ARCHIVES,O
OF,O
BONE,O
AND,O
JOINT,O
SURGERY,CAUSE_OF_DEATH
CASE,O
REPORT,O
Association,O
of,O
New,O
Coronavirus,O
Disease,CAUSE_OF_DEATH
with,O
Fragility,O
Hip,O
and,O
Lower,O
Limb,O
Fractures,O
in,O
Elderly,O
Patients,O
Mohammad,PERSON
Javad,PERSON
Shariyate,O
.,O
MD1,O
;,O
Amir,PERSON
R.,PERSON
Kachooei,PERSON
.,O
MD2,O
The,O
novel,O
coronavirus,O
‐,O
in,O
‐,O
duced,O
infection,CAUSE_OF_DEATH
(,O
COVID,O
‐,O
19,NUMBER
),O
was,O
declared,O
a,O
pandemic,O
by,O
the,O
World,MISC
Health,ORGANIZATION
Organization,ORGANIZATION
on,O
March,DATE
11,DATE
.,DATE
2020,DATE
.,O
Iran,COUNTRY
is,O
one,NUMBER
of,O
the,O
coun,O
‐,O
tries,O
with,O
a,O
high,O
incidence,O
of,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
.,O
Data,O
on,O
three,NUMBER
patients,O
with,O
fragility,O
hip,O
fracture,O
and,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
were,O
collected,O
from,O
one,NUMBER
hospital,O
located,O
in,O
Badrud,LOCATION
.,O
Isfahan,LOCATION
.,O
Iran,COUNTRY
.,O
from,O
March,DATE
1,DATE
.,DATE
2010,DATE
.,O
to,O
March,DATE
30,DATE
.,DATE
2020,DATE
.,O
All,O
patients,O
were,O
elderly,O
and,O
had,O
fracture,O
induced,O
by,O
fall,DATE
from,O
standing,O
height,O
.,O
All,O
pa,O
‐,O
tients,O
(,O
n,O
=,O
3,NUMBER
),O
were,O
admitted,O
with,O
fragility,O
hip,O
fracture,O
due,O
to,O
low,O
energy,O
trauma,O
.,O
The,O
most,O
common,O
symptoms,O
were,O
weakness,O
and,O
fa,O
‐,O
tigue,O
.,O
Positive,O
C,O
‐,O
reactive,O
protein,O
(,O
CRP,O
),O
and,O
Leukopenia,LOCATION
were,O
the,O
most,O
common,O
abnormal,O
laboratory,O
evaluations,O
.,O
According,O
to,O
the,O
re,O
‐,O
sults,O
.,O
two,NUMBER
patients,O
underwent,O
surgical,O
treatment,O
.,O
and,O
one,NUMBER
patient,O
had,O
negative,O
reverse,O
transcription,O
‐,O
CRP,ORGANIZATION
;,O
however,O
.,O
all,O
of,O
them,O
un,O
‐,O
derwent,O
medical,O
treatment,O
for,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
.,O
There,O
is,O
a,O
possible,O
relationship,O
between,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
and,O
fragility,O
hip,O
fracture,O
in,O
elderly,O
patients,O
.,O
It,O
could,O
be,O
induced,O
by,O
fatigue,O
and,O
weakness,O
due,O
to,O
COVID,O
‐,O
19,NUMBER
disease,CAUSE_OF_DEATH
.,O
COVOID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
should,O
be,O
considered,O
in,O
elderly,O
patients,O
with,O
fragility,O
hip,O
fracture,O
during,O
the,O
coronavirus,O
pandemic,O
.,O
Level,O
of,O
evidence,O
:,O
IV,NUMBER
Keywords,O
:,O
Coronavirus,O
disease,CAUSE_OF_DEATH
2019,DATE
(,O
COVID,O
‐,O
19,NUMBER
),O
.,O
Fracture,O
.,O
Hip,O
n,O
December,DATE
2019,DATE
.,O
an,O
outbreak,O
of,O
pneumonia,CAUSE_OF_DEATH
of,O
unknown,O
origin,O
developed,O
in,O
Wuhan,CITY
of,O
Hubei,STATE_OR_PROVINCE
Province,LOCATION
.,O
China,COUNTRY
(,O
1,NUMBER
),O
.,O
By,O
January,DATE
7,DATE
.,DATE
2020,DATE
.,O
Chinese,NATIONALITY
scientists,O
confirmed,O
that,O
the,O
outbreak,O
was,O
caused,O
by,O
a,O
novel,O
coronavirus,O
.,O
initially,O
referred,O
to,O
as,O
the,O
2019,DATE
‐,O
nCoV,O
(,O
2,NUMBER
),O
.,O
The,O
dis,O
‐,O
ease,O
is,O
now,DATE
termed,O
as,O
coronavirus,O
disease,CAUSE_OF_DEATH
2019,DATE
(,O
COVID,O
‐,O
19,NUMBER
),O
by,O
the,O
WHO,O
.,O
It,O
is,O
now,DATE
evident,O
that,O
most,O
cases,O
of,O
COVID,O
‐,O
19,NUMBER
develop,O
mild,O
respiratory,O
and,O
constitutional,O
symptoms,O
(,O
3,NUMBER
),O
while,O
some,O
patients,O
might,O
remain,O
asymptomatic,O
(,O
3.4,NUMBER
),O
.,O
The,O
reverse,O
transcription,O
poly,O
‐,O
merase,O
chain,O
reaction,O
(,O
RTPCR,O
),O
has,O
a,O
fair,O
detection,O
rate,O
of,O
30,PERCENT
%,PERCENT
to,O
60,PERCENT
%,PERCENT
at,O
initial,O
presentation,O
with,O
several,O
other,O
limitations,O
(,O
5,NUMBER
),O
.,O
In,O
a,O
recent,O
report,O
from,O
China,COUNTRY
.,O
chest,O
CT,STATE_OR_PROVINCE
scan,O
had,O
a,O
sensitivity,O
of,O
97,PERCENT
%,PERCENT
for,O
diagnosing,O
COVID,O
‐,O
19,NUMBER
which,O
is,O
superior,O
to,O
RT,O
‐,O
PCR,O
(,O
6,NUMBER
),O
.,O
Irans,MISC
ministry,O
of,O
health,O
introduced,O
a,O
RT,O
‐,O
PCR,O
as,O
a,O
gold,O
standard,O
for,O
the,O
diagnosis,O
of,O
COVID,O
‐,O
19,NUMBER
.,O
because,O
it,O
is,O
available,O
and,O
cheap,O
‐,O
er,O
in,O
Iran,COUNTRY
which,O
is,O
more,O
positive,O
early,O
in,O
the,O
course,O
of,O
the,O
dis,O
‐,O
ease,O
and,O
can,O
be,O
used,O
as,O
a,O
screening,O
tool,O
with,O
higher,O
sensitivity,O
than,O
In,O
Iran,COUNTRY
.,O
the,O
first,ORDINAL
cases,O
of,O
COVID,O
‐,O
19,NUMBER
were,O
officially,O
report,O
‐,O
ed,O
between,O
February,DATE
19,DATE
and,DATE
23,DATE
.,DATE
2020,DATE
and,O
it,O
soon,O
became,O
clear,O
that,O
Iran,COUNTRY
is,O
one,NUMBER
of,O
the,O
countries,O
that,O
is,O
worst,O
‐,O
hit,O
by,O
COVID,O
‐,O
19,NUMBER
out,O
‐,O
break,O
(,O
7,NUMBER
.,O
8,NUMBER
),O
.,O
Badrood,ORGANIZATION
General,ORGANIZATION
Hospital,ORGANIZATION
in,O
Badrood,LOCATION
city,O
near,O
Kashan,CITY
and,O
Qom,O
‐,O
the,O
epicenters,O
of,O
Iran,COUNTRY
is,O
covering,O
30.000,NUMBER
popu,O
‐,O
lation,O
where,O
we,O
diagnosed,O
59,NUMBER
patients,O
with,O
a,O
positive,O
RT,O
‐,O
PCR,O
and,O
more,O
than,O
70,NUMBER
patients,O
were,O
treated,O
based,O
on,O
highly,O
suspected,O
chest,O
CT,STATE_OR_PROVINCE
scan,O
until,O
March,DATE
2,DATE
.,DATE
2020,DATE
.,O
.,O
This,O
number,O
represents,O
a,O
high,O
prevalence,O
of,O
Arch,O
Bone,O
Jt,O
Surg,O
.,O
2020,DATE
;,O
8,NUMBER
(,O
Supplement,O
1,NUMBER
),O
:,O
297,NUMBER
‐,O
301,NUMBER
.,O
Doi,PERSON
:,O
10.22038,NUMBER
/,O
abjs,O
.2020.47626.2333,NUMBER
THE,O
ARCHIVES,O
OF,O
BONE,O
AND,O
JOINT,O
SURGERY,CAUSE_OF_DEATH
.,O
ABJS.MUMS.AC.IR,O
VOLUME,O
8,NUMBER
.,O
SUPPLEMENT,O
1,NUMBER
.,O
APRIL,DATE
2020,DATE
of,O
our,O
hospital,O
between,O
January,DATE
2018,DATE
until,O
January,DATE
2020,DATE
.,O
we,O
found,O
only,O
17,NUMBER
patients,O
admitted,O
with,O
the,O
diagnosis,O
of,O
fragility,O
hip,O
fracture,O
(,O
approximately,O
0.7,NUMBER
patients,O
a,DURATION
month,DURATION
),O
.,O
Notably,O
only,O
over,O
a,DATE
month,DATE
in,DATE
March,DATE
2020,DATE
.,O
we,O
admitted,O
3,NUMBER
elderly,O
patients,O
with,O
fragility,O
hip,O
fracture,O
all,O
of,O
whom,O
were,O
diagnosed,O
positive,O
for,O
COVID,O
‐,O
19,NUMBER
based,O
on,O
chest,O
CT,STATE_OR_PROVINCE
scan,O
study,O
.,O
Case,O
presentation,O
The,O
pa,O
‐,O
tient,O
was,O
73,DURATION
year,DURATION
old,DURATION
male,O
admitted,O
with,O
preoperative,O
laboratory,O
exam,O
did,O
not,O
show,O
any,O
abnormality,O
.,O
However,O
.,O
he,O
was,O
complaining,O
of,O
a,O
recent,O
generalized,O
weakness,O
.,O
He,O
underwent,O
surgical,O
fixation,O
un,O
‐,O
der,O
spinal,O
anesthesia,O
and,O
intravenous,O
sedation,O
.,O
His,O
FRAGILE,O
HIP,O
FRACTURE,O
AND,O
CORONAVIRUS,O
oxygen,O
saturation,O
dropped,O
to,O
90,PERCENT
%,PERCENT
during,O
surgery,CAUSE_OF_DEATH
which,O
raised,O
to,O
96,PERCENT
%,PERCENT
with,O
face,O
mask,O
and,O
O2,O
supplement,O
.,O
He,O
was,O
transferred,O
to,O
post,O
anesthesia,O
care,O
unit,O
(,O
PACU,ORGANIZATION
),O
and,O
was,O
dis,O
‐,O
charged,O
from,O
the,O
hospital,O
after,O
2,DURATION
days,DURATION
.,O
He,O
returned,O
to,O
the,O
hospi,O
‐,O
tal,O
3,DURATION
days,DURATION
after,O
discharge,O
with,O
new,O
onset,O
fever,CAUSE_OF_DEATH
.,O
weakness,O
.,O
dysp,O
‐,O
nea,O
.,O
and,O
anorexia,CAUSE_OF_DEATH
.,O
Initial,O
evaluation,O
ruled,O
out,O
surgical,O
site,O
infection,CAUSE_OF_DEATH
while,O
the,O
chest,O
X,O
‐,O
ray,O
was,O
suggestive,O
of,O
COVID,O
‐,O
19,NUMBER
lead,O
‐,O
ing,O
to,O
showed,O
positive,O
CRP,ORGANIZATION
and,O
elevated,O
liver,O
function,O
tests,O
in,O
‐,O
cluding,O
AST,ORGANIZATION
.,O
ALT,O
.,O
and,O
LDH,ORGANIZATION
.,O
Complete,O
blood,O
count,TITLE
(,O
CBC,ORGANIZATION
),O
demonstrat,O
‐,O
ed,O
7.7109,NUMBER
white,O
blood,O
cells,O
/,O
L,O
with,O
81,PERCENT
%,PERCENT
neutrophils,O
and,O
13,PERCENT
%,PERCENT
lym,O
‐,O
phocytes,O
illustrating,O
significant,O
lymphocytopenia,O
.,O
Moreoevr,O
.,O
chest,O
HRCT,O
was,O
diagnostic,O
predictive,O
value,O
of,O
the,O
findings,O
.,O
PCR,O
was,O
considered,O
false,O
THE,O
ARCHIVES,O
OF,O
BONE,O
AND,O
JOINT,O
SURGERY,CAUSE_OF_DEATH
.,O
AB,STATE_OR_PROVINCE
‐,O
JS.MUMS.AC.IR,O
VOLUME,O
8,NUMBER
.,O
SUPPLEMENT,O
1,NUMBER
.,O
APRIL,DATE
2020,DATE
FRAGILE,O
HIP,O
FRACTURE,O
AND,O
CORONAVIRUS,O
from,O
stand,O
height,O
leve,O
.,O
negative,O
and,O
patient,O
was,O
planned,O
to,O
receive,O
treatment,O
per,O
protocol,O
.,O
The,O
pa,O
‐,O
tient,O
was,O
a,O
69,DURATION
year,DURATION
old,DURATION
male,O
admitted,O
with,O
our,O
experience,O
with,O
patient,O
1,NUMBER
.,O
we,O
carefully,O
evaluated,O
the,O
patient,O
.,O
He,O
had,O
no,O
fever,CAUSE_OF_DEATH
and,O
no,O
cough,O
but,O
he,O
was,O
complaining,O
of,O
weakness,O
.,O
The,O
chest,O
CT,STATE_OR_PROVINCE
scan,O
was,O
lymphocytopenia,O
(,O
0.6109,NUMBER
cells,O
/,O
L,O
),O
was,O
present,DATE
while,O
other,O
laboratory,O
studies,O
were,O
in,O
a,O
normal,O
range,O
.,O
The,O
patients,O
were,O
treated,O
in,O
a,O
same,O
manner,O
as,O
was,O
done,O
for,O
The,O
patient,O
was,O
a,O
93,NUMBER
year,DURATION
old,O
female,O
admitted,O
with,O
showed,O
a,O
low,O
grade,O
fever,CAUSE_OF_DEATH
along,O
with,O
cough,O
and,O
feeling,O
of,O
fatigue,O
.,O
Primary,O
laboratory,O
study,O
revealed,O
leukocytosis,O
(,O
1.1109,NUMBER
cells,O
/,O
L,O
),O
with,O
8,PERCENT
%,PERCENT
lymphocyte,O
count,TITLE
(,O
signifi,O
‐,O
cant,O
lymphopenia,O
),O
.,O
A,DURATION
second,DURATION
CBC,ORGANIZATION
after,O
2,DURATION
days,DURATION
showed,O
5.5109,NUMBER
white,O
blood,O
cell,O
/,O
L,O
consisting,O
of,O
13,PERCENT
%,PERCENT
lymphocyte,O
.,O
In,O
addition,O
.,O
CRP,ORGANIZATION
and,O
LDH,ORGANIZATION
were,O
55,NUMBER
and,O
472,NUMBER
.,O
respectively,O
while,O
other,O
laboratory,O
studies,O
were,O
in,O
a,O
normal,O
range,O
.,O
and,O
the,O
subsequent,O
chest,O
CT,STATE_OR_PROVINCE
scan,O
was,O
di,O
‐,O
agnostic,RELIGION
for,O
urged,O
to,O
postpone,O
surgery,CAUSE_OF_DEATH
due,O
to,O
severe,O
pulmonary,O
THE,O
ARCHIVES,O
OF,O
BONE,O
AND,O
JOINT,O
SURGERY,CAUSE_OF_DEATH
.,O
ABJS.MUMS.AC.IR,O
VOLUME,O
8,NUMBER
.,O
SUPPLEMENT,O
1,NUMBER
.,O
APRIL,DATE
2020,DATE
All,O
three,NUMBER
patients,O
received,O
oseltamivir,O
and,O
hydroxychloroquine,O
.,O
One,NUMBER
patient,O
also,O
received,O
corticosteroid,O
.,O
At,O
the,O
time,DATE
of,O
preparing,O
this,O
paper,O
.,O
all,O
three,NUMBER
patients,O
are,O
still,O
hospitalized,O
and,O
is,O
in,O
the,O
ICU,O
.,O
To,O
our,O
knowledge,O
.,O
there,O
are,O
only,O
two,NUMBER
reports,O
about,O
the,O
possible,O
association,O
between,O
COVID,O
‐,O
19,NUMBER
and,O
trauma,O
in,O
the,O
recent,O
literature,O
.,O
The,O
first,ORDINAL
was,O
reported,O
by,O
Khaza,MISC
‐,O
ei,O
et,O
al,O
(,O
9,NUMBER
),O
.,O
He,O
reported,O
incidental,O
diagnosis,O
of,O
COVID,O
‐,O
19,NUMBER
in,O
trauma,O
patients,O
with,O
which,O
he,O
raised,O
the,O
possible,O
association,O
be,O
‐,O
tween,O
provisional,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
and,O
traumatic,O
events,O
.,O
They,O
did,O
not,O
mention,O
fragility,O
fractures,O
in,O
specific,O
.,O
but,O
they,O
report,O
‐,O
ed,O
falling,O
and,O
car,CAUSE_OF_DEATH
accident,CAUSE_OF_DEATH
as,O
the,O
most,O
frequent,O
mechanisms,O
of,O
injury,O
.,O
Interestingly,O
.,O
most,O
of,O
the,O
patient,O
did,O
not,O
have,O
any,O
symp,O
‐,O
toms,O
related,O
to,O
COVID,O
‐,O
19,NUMBER
at,O
presentation,O
.,O
Second,ORDINAL
study,O
reported,O
by,O
bobin,O
et,O
al,O
reported,O
10,NUMBER
patients,O
with,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
after,O
sustaining,O
a,O
traumatic,O
fracture,O
in,O
a,O
motor,O
‐,O
vehicle,O
accident,CAUSE_OF_DEATH
(,O
10,NUMBER
),O
.,O
Of,O
these,O
.,O
3,NUMBER
patients,O
were,O
negative,O
on,O
RT,O
‐,O
PCR,O
exam,O
.,O
but,O
all,O
showed,O
diagnostic,O
features,O
on,O
chest,O
CT,STATE_OR_PROVINCE
scan,O
.,O
They,O
concluded,O
that,O
presen,O
‐,O
tation,O
of,O
symptoms,O
was,O
not,O
different,O
from,O
other,O
COVID,O
‐,O
19,NUMBER
patients,O
and,O
was,O
unrelated,O
to,O
having,O
a,O
fracture,O
.,O
They,O
also,O
concluded,O
that,O
lymphopenia,O
was,O
more,O
likely,O
to,O
be,O
found,O
in,O
patients,O
with,O
a,O
frac,O
‐,O
ture,O
.,O
The,O
observations,O
could,O
be,O
just,O
a,O
coincidence,O
.,O
but,O
there,O
is,O
a,O
possible,O
relationship,O
between,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
and,O
fragility,O
fractures,O
as,O
a,O
result,O
of,O
a,O
fall,DATE
from,O
a,O
standing,O
due,O
to,O
weakness,O
and,O
fatigue,O
arising,O
from,O
the,O
underlying,O
disease,CAUSE_OF_DEATH
.,O
In,O
our,O
case,O
study,O
.,O
the,O
most,O
common,O
chief,O
complaint,O
was,O
weakness,O
and,O
fatigue,O
.,O
FRAGILE,O
HIP,O
FRACTURE,O
AND,O
CORONAVIRUS,O
Based,O
on,O
the,O
related,O
algo,O
‐,O
rithm,O
described,O
by,O
British,ORGANIZATION
Orthopedic,ORGANIZATION
Association,ORGANIZATION
for,O
the,O
manage,O
‐,O
ment,O
of,O
orthopedic,O
patients,O
during,O
coronavirus,O
pandemic,O
.,O
the,O
care,O
of,O
patients,O
with,O
lower,O
limb,O
fragility,O
fractures,O
remain,O
urgent,O
and,O
is,O
a,O
surgical,O
priority,O
which,O
highlights,O
the,O
importance,O
of,O
vigili,O
‐,O
ty,O
in,O
this,O
group,O
of,O
Most,O
patients,O
with,O
fragility,O
lower,O
extremity,O
fractures,O
are,O
old,O
and,O
have,O
other,O
underlying,O
conditions,O
such,O
as,O
hypertension,CAUSE_OF_DEATH
.,O
diabetes,CAUSE_OF_DEATH
.,O
and,O
heart,CAUSE_OF_DEATH
disease,CAUSE_OF_DEATH
.,O
which,O
leads,O
to,O
a,O
lengthy,O
hospital,O
stay,O
as,O
well,O
as,O
requiring,O
PACU,ORGANIZATION
.,O
both,O
increasing,O
the,O
chance,O
of,O
transmitting,O
infection,CAUSE_OF_DEATH
to,O
the,O
health,O
care,O
workers,O
and,O
other,O
patients,O
(,O
12,NUMBER
),O
.,O
On,O
the,O
other,O
hand,O
.,O
the,O
higher,O
death,O
rate,O
was,O
primarily,O
in,O
elderly,O
people,O
.,O
possibly,O
due,O
to,O
a,O
weaker,O
immune,O
system,O
that,O
permits,O
faster,O
progression,O
of,O
viral,O
infection,CAUSE_OF_DEATH
(,O
13,NUMBER
.,O
14,NUMBER
),O
.,O
Additionally,O
.,O
the,O
stress,O
associated,O
with,O
the,O
fracture,O
and,O
the,O
surgery,CAUSE_OF_DEATH
itself,O
can,O
trigger,O
a,O
series,O
of,O
oxidative,O
stress,O
re,O
‐,O
sponses,O
and,O
excessive,O
inflammation,O
making,O
them,O
vulnerable,O
to,O
more,O
severe,O
course,O
of,O
infection,CAUSE_OF_DEATH
(,O
15,NUMBER
),O
.,O
So,O
.,O
it,O
is,O
advised,O
to,O
carefully,O
evaluate,O
the,O
elderly,O
patients,O
with,O
fragility,O
lower,O
extremity,O
fracture,O
during,O
an,O
outbreak,O
of,O
COVID,O
‐,O
19,NUMBER
in,O
order,O
to,O
protect,O
the,O
health,O
and,O
safety,O
of,O
the,O
health,O
care,O
workers,O
.,O
World,O
Health,O
Orga,O
‐,O
nization,O
(,O
WHO,O
),O
guideline,O
has,O
instructed,O
airway,O
management,O
of,O
con,O
‐,O
firmed,O
or,O
suspected,O
COVID,O
‐,O
19,NUMBER
patients,O
to,O
reduce,O
the,O
risk,O
of,O
viral,O
transmission,O
(,O
16,NUMBER
),O
.,O
Nevertheless,O
.,O
to,O
avoid,O
any,O
airway,O
manipula,O
‐,O
tion,O
.,O
the,O
use,O
of,O
regional,O
anesthesia,O
(,O
RA,O
),O
techniques,O
are,O
pre,O
‐,O
ferred,O
when,O
possible,O
(,O
17,NUMBER
),O
.,O
The,O
main,O
advantage,O
would,O
be,O
the,O
avoidance,O
of,O
airway,O
instrumentation,O
and,O
patient,O
coughing,O
during,O
intubation,O
and,O
extubation,O
.,O
which,O
reduces,O
the,O
risk,O
of,O
direct,O
con,O
‐,O
tact,O
with,O
generated,O
aerosols,O
and,O
dispersion,O
During,O
a,O
pandemic,O
.,O
it,O
is,O
suggested,O
to,O
consider,O
everyone,O
a,O
COVID,O
‐,O
19,NUMBER
positive,O
to,O
take,O
enough,O
precautions,O
when,O
treating,O
a,O
patient,O
.,O
However,O
.,O
elderly,O
pa,O
‐,O
tients,O
with,O
fragile,O
lower,O
extremity,O
fractures,O
are,O
those,O
who,O
po,O
‐,O
tentially,O
pose,O
a,O
greater,O
risk,O
to,O
the,O
health,O
care,O
workers,O
.,O
We,O
sug,O
‐,O
gest,O
being,O
vigilant,O
when,O
seeing,O
the,O
patients,O
and,O
use,O
sufficient,O
personal,O
protective,O
equipment,O
(,O
PPE,O
),O
when,O
interacting,O
.,O
Careful,O
as,O
‐,O
sessment,O
using,O
chest,O
CT,STATE_OR_PROVINCE
scan,O
and,O
other,O
lab,O
tests,O
are,O
recommended,O
during,O
pandemic,O
regardless,O
of,O
having,O
any,O
symptoms,O
to,O
diagnose,O
and,O
separate,O
the,O
COVID,O
‐,O
19,NUMBER
patient,O
as,O
soon,O
as,O
possible,O
.,O
Mohammad,PERSON
Javad,PERSON
Shariyate,PERSON
MD1,PERSON
Amir,PERSON
R.,PERSON
Kachooei,PERSON
MD2,O
Isfahan,LOCATION
.,O
Iran,ORGANIZATION
Sciences,ORGANIZATION
.,O
Mashhad,CITY
.,O
Iran,COUNTRY
THE,O
ARCHIVES,O
OF,O
BONE,O
AND,O
JOINT,O
SURGERY,CAUSE_OF_DEATH
.,O
AB,STATE_OR_PROVINCE
‐,O
JS.MUMS.AC.IR,O
VOLUME,O
8,NUMBER
.,O
SUPPLEMENT,O
1,NUMBER
.,O
APRIL,DATE
2020,DATE
FRAGILE,O
HIP,O
FRACTURE,O
AND,O
CORONAVIRUS,O
1,NUMBER
.,O
Huang,PERSON
C,PERSON
.,O
Wang,O
Y,O
.,O
Li,PERSON
X,PERSON
.,O
et,O
al,O
.,O
Clini,O
‐,O
cal,O
features,O
of,O
patients,O
infected,O
with,O
2019,DATE
novel,O
coronavirus,O
in,O
Wuhan,CITY
.,O
China,COUNTRY
.,O
Lancet,O
2020,DATE
;,O
395,NUMBER
:,O
497e506,NUMBER
2,NUMBER
.,O
Zhu,PERSON
N,PERSON
.,O
Zhang,PERSON
D,PERSON
.,O
Wang,PERSON
W,O
.,O
et,O
al,O
.,O
A,O
novel,O
coronavirus,O
from,O
patients,O
with,O
pneumonia,CAUSE_OF_DEATH
in,O
China,COUNTRY
.,O
2019,DATE
.,O
N,O
3,NUMBER
.,O
Wu,O
Z,O
.,O
McGoogan,PERSON
JM,PERSON
.,O
Characteristics,O
of,O
and,O
im,O
‐,O
portant,O
lessons,O
from,O
the,O
coronavirus,O
disease,CAUSE_OF_DEATH
2019,DATE
(,O
COVID,O
‐,O
19,NUMBER
),O
out,O
‐,O
break,O
in,O
China,COUNTRY
:,O
summary,O
of,O
a,O
report,O
of,O
72,NUMBER
314,NUMBER
cases,O
from,O
the,O
Chi,O
‐,O
nese,O
Center,ORGANIZATION
for,ORGANIZATION
Disease,ORGANIZATION
Control,ORGANIZATION
and,O
Preven,O
‐,O
tion,O
.,O
Jama,PERSON
.,O
2020,DATE
characteristics,O
of,O
24,NUMBER
asymptomatic,O
infections,CAUSE_OF_DEATH
with,O
COVID,O
‐,O
19,NUMBER
screened,O
among,O
close,O
contacts,O
in,O
Nanjing,CITY
.,O
China,COUNTRY
.,O
Science,O
China,COUNTRY
Life,ORGANIZATION
Sciences,ORGANIZATION
.,O
2020:1,NUMBER
‐,O
6,NUMBER
.,O
5,NUMBER
.,O
Yang,O
Y,O
.,O
Yang,PERSON
M,O
.,O
Shen,O
C,O
.,O
Wang,O
F,O
.,O
Yuan,PERSON
J,O
.,O
Li,PERSON
J,PERSON
.,O
et,O
al,O
.,O
Laboratory,O
diagnosis,O
and,O
monitoring,O
the,O
viral,O
6,NUMBER
.,O
Ai,O
T,O
.,O
Yang,PERSON
Z,PERSON
.,O
Hou,PERSON
H,PERSON
.,O
Zhan,PERSON
C,PERSON
.,O
Chen,PERSON
C,O
.,O
Lv,O
W,O
.,O
et,O
al,O
.,O
Correlation,O
of,O
chest,O
CT,STATE_OR_PROVINCE
and,O
RT,O
‐,O
PCR,O
testing,O
in,O
coronavirus,O
disease,CAUSE_OF_DEATH
2019,DATE
(,O
COVID,O
‐,O
19,NUMBER
),O
in,O
China,COUNTRY
:,O
A,O
7,NUMBER
.,O
MahdaviA,O
.,O
KhaliliN,PERSON
.,O
DavarpanahAH,O
.,O
FaghihiT,O
.,O
Mahdavi,PERSON
A,O
.,O
Haseli,PERSON
S,O
.,O
et,O
al,O
.,O
Radiologic,O
Management,O
of,O
COVID,O
‐,O
19,NUMBER
:,O
Preliminary,O
Experience,O
of,O
the,O
Iranian,NATIONALITY
Society,O
of,O
Radi,PERSON
‐,PERSON
ology,O
COVID,O
‐,O
19,NUMBER
Consultant,TITLE
Group,O
8,NUMBER
.,O
National,ORGANIZATION
Committee,ORGANIZATION
on,O
COVID,O
‐,O
19,NUMBER
Epidemiology,O
.,O
Daily,SET
Situation,O
Report,O
on,O
Coronavirus,O
disease,CAUSE_OF_DEATH
(,O
COVID19,O
),O
in,O
Iran,COUNTRY
;,O
March,DATE
13,DATE
.,DATE
2020,DATE
.,O
Archives,O
of,O
Academic,O
Emergency,O
Medicine,O
.,O
2020,DATE
;,O
8,NUMBER
(,O
1,NUMBER
),O
:,O
e23,O
.,O
9,NUMBER
.,O
Khazaei,PERSON
M,O
.,O
Asgari,PERSON
R,PERSON
.,O
Zarei,PERSON
E,O
.,O
Mohar,PERSON
‐,O
ramzad,O
Y,O
.,O
Haghighatkhah,PERSON
H,PERSON
.,O
Sanei,PERSON
Taheri,PERSON
M.,O
Incidentally,O
Diagnosed,O
COVID,O
‐,O
19,NUMBER
In,O
‐,O
fection,O
in,O
Trauma,O
Patients,O
;,O
a,O
Clinical,O
Experience,O
.,O
Arch,O
Acad,O
Emerg,O
Med,O
.,O
2020,DATE
;,O
10,NUMBER
.,O
Bobin,PERSON
Mi,PERSON
.,O
Lang,PERSON
Chen,PERSON
.,O
Yuan,PERSON
Xiong,PERSON
.,O
Hang,O
Xue,O
.,O
Wu,PERSON
Zhou,PERSON
.,O
and,O
Guohui,PERSON
Liu,PERSON
.,O
Characteristics,O
and,O
Early,O
Prognosis,O
of,O
COVID,O
‐,O
19,NUMBER
Infection,CAUSE_OF_DEATH
in,O
Fracture,O
Patients,O
.,O
J,PERSON
Bone,PERSON
Joint,O
Surg,O
Am,O
.,O
2020,DATE
;,O
00:1,NUMBER
‐,O
9,NUMBER
11,NUMBER
.,O
British,ORGANIZATION
Orthopedic,ORGANIZATION
Association,ORGANIZATION
.,O
BOAST,O
‐,O
Management,O
of,O
patients,O
with,O
urgent,O
orthopaedic,O
conditions,O
and,O
trauma,O
during,O
the,O
coronavirus,O
pandemic,O
.,O
Available,O
12,NUMBER
.,O
HIP,O
AT,O
‐,O
TACK,O
Investigators,O
.,O
Accelerated,O
surgery,CAUSE_OF_DEATH
versus,O
standard,O
care,O
in,O
hip,O
fracture,O
(,O
HIP,O
ATTACK,CAUSE_OF_DEATH
),O
:,O
an,O
international,O
.,O
randomised,O
.,O
con,O
‐,O
trolled,O
trial,O
.,O
Lancet,O
.,O
13,NUMBER
.,O
W.,PERSON
Wang,PERSON
.,O
J.,PERSON
Tang,PERSON
.,O
F.,PERSON
Wei,PERSON
.,O
Updated,O
un,O
‐,O
derstanding,O
of,O
the,O
outbreak,O
of,O
2019,DATE
novel,O
coronavirus,O
(,O
2019,DATE
‐,O
nCoV,O
),O
in,O
Wuhan,CITY
.,O
China,COUNTRY
.,O
J.,O
Med,O
.,O
Virol,O
.,O
92,NUMBER
(,O
4,NUMBER
),O
(,O
2020,DATE
),O
441447,NUMBER
.,O
14,NUMBER
.,O
Q.,O
Li,PERSON
.,O
X.,PERSON
Guan,PERSON
.,O
P.,PERSON
Wu,PERSON
.,O
X.,PERSON
Wang,PERSON
.,O
L.,PERSON
Zhou,PERSON
.,O
Y.,PERSON
Tong,PERSON
.,O
et,O
al.,O
.,O
Early,O
trans,O
‐,O
mission,O
dynamics,O
in,O
wuhan,O
.,O
China,COUNTRY
.,O
of,O
novel,O
coronavirus,O
‐,O
infected,O
pneumonia,CAUSE_OF_DEATH
.,O
N.,PERSON
Engl,PERSON
.,O
J.,O
Med,O
.,O
15,NUMBER
.,O
Mazidi,O
M,O
.,O
Shivappa,PERSON
N,PERSON
.,O
Wirth,PERSON
MD,STATE_OR_PROVINCE
.,O
Hebert,PERSON
JR,PERSON
.,O
Vatanparast,PERSON
H,PERSON
.,O
Kengne,ORGANIZATION
AP,ORGANIZATION
.,O
The,O
association,O
between,O
di,O
‐,O
etary,O
inflammatory,O
properties,O
and,O
bone,O
mineral,O
density,O
and,O
risk,O
of,O
fracture,O
in,O
US,COUNTRY
adults,O
.,O
Eur,PERSON
J,PERSON
Clin,PERSON
16,NUMBER
.,O
World,O
Health,O
Organiza,O
‐,O
tion,O
.,O
Coronavirus,O
disease,CAUSE_OF_DEATH
(,O
COVID,O
‐,O
19,NUMBER
),O
technical,O
guidance,O
:,O
infec,O
‐,O
tion,O
prevention,O
novelcoronavirus,O
‐,O
2019,DATE
/,O
technical,O
‐,O
guidance,O
/,O
infec,O
‐,O
tionprevention,O
‐,O
and,O
‐,O
control,O
(,O
accessed,O
March,DATE
2020,DATE
),O
.,O
17,NUMBER
.,O
Peng,PERSON
PW,PERSON
.,O
Ho,O
PL,O
.,O
Hota,PERSON
SS,O
.,O
Outbreak,O
of,O
a,O
new,O
coronavirus,O
:,O
what,O
anaesthetists,O
should,O
know,O
.,O
British,NATIONALITY
18,NUMBER
.,O
Tan,O
TK,O
.,O
How,O
severe,O
acute,O
respiratory,O
syndrome,O
(,O
SARS,O
),O
affected,O
the,O
Department,ORGANIZATION
of,ORGANIZATION
Anaesthesia,ORGANIZATION
at,O
Singa,O
‐,O
pore,O
General,ORGANIZATION
Hospital,ORGANIZATION
.,O
Anaesthesia,O
and,O
intensive,O
care,O
.,O
2004,DATE
Jun,DATE
;,O
32,NUMBER
(,O
3,NUMBER
),O
:,O
394,NUMBER
‐,O
400,NUMBER
.,O
